These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20936946)
1. Mechanisms of monoclonal antibody-drug interactions. Zhou H; Mascelli MA Annu Rev Pharmacol Toxicol; 2011; 51():359-72. PubMed ID: 20936946 [TBL] [Abstract][Full Text] [Related]
2. Molecular, biologic, and pharmacokinetic properties of monoclonal antibodies: impact of these parameters on early clinical development. Mascelli MA; Zhou H; Sweet R; Getsy J; Davis HM; Graham M; Abernethy D J Clin Pharmacol; 2007 May; 47(5):553-65. PubMed ID: 17379759 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies in human organ transplantation and auto-immune diseases. Wijdenes J; Roy C; Morel-Fourrier B; Racadot E Therapie; 1992; 47(4):283-7. PubMed ID: 1494788 [TBL] [Abstract][Full Text] [Related]
5. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216 [TBL] [Abstract][Full Text] [Related]
6. Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases. Brennan FR; Cauvin A; Tibbitts J; Wolfreys A Drug Dev Res; 2014 May; 75(3):115-61. PubMed ID: 24782266 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228 [TBL] [Abstract][Full Text] [Related]
8. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities. Sanders J; Miguel RN; Furmaniak J; Smith BR Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929 [TBL] [Abstract][Full Text] [Related]
9. Laboratory monitoring of therapy with OKT3 and other murine monoclonal antibodies. Colvin RB; Preffer FI Clin Lab Med; 1991 Sep; 11(3):693-714. PubMed ID: 1934971 [TBL] [Abstract][Full Text] [Related]
11. Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency. Scallon B; Cai A; Radewonuk J; Naso M Mol Immunol; 2004 May; 41(1):73-80. PubMed ID: 15140577 [TBL] [Abstract][Full Text] [Related]
13. Are monoclonal antibodies a safe treatment for cancer during pregnancy? Sarno MA; Mancari R; Azim HA; Colombo N; Peccatori FA Immunotherapy; 2013 Jul; 5(7):733-41. PubMed ID: 23829624 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppression with monoclonal antibodies in multiple sclerosis. Hafler DA; Weiner HL Neurology; 1988 Jul; 38(7 Suppl 2):42-7. PubMed ID: 3260356 [TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells. Honeychurch J; Glennie MJ; Illidge TM Cancer Res; 2005 Aug; 65(16):7493-501. PubMed ID: 16103104 [TBL] [Abstract][Full Text] [Related]
16. Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients. Kang HJ; Park JS; Kim DW; Lee J; Jeong YJ; Choi SM; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ Respir Med; 2012 Mar; 106(3):443-50. PubMed ID: 22154502 [TBL] [Abstract][Full Text] [Related]